What are the Challenges of Targeting ROS in Cancer Therapy?
The major challenge in targeting ROS for cancer therapy is achieving selectivity. Normal cells also produce ROS and rely on antioxidant defenses for survival. Therefore, therapeutic strategies must be carefully designed to selectively increase ROS in cancer cells without causing excessive damage to normal tissues.
